CURACLE CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5,890 KRW | -2.00% |
|
-5.15% | -49.36% |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 |
|---|---|---|---|
| Capitalization 1 | 310,021 | 157,152 | 161,138 |
| Enterprise Value (EV) 1 | 272,491 | 133,705 | 138,729 |
| P/E ratio | -41.8 x | -13.7 x | -13.9 x |
| Yield | - | - | - |
| Capitalization / Revenue | 49,564,109 x | 43,862,105 x | 15,652,954 x |
| EV / Revenue | 43,564,056 x | 37,318,037 x | 13,476,205 x |
| EV / EBITDA | -42 x | -11.6 x | -14.1 x |
| EV / FCF | -14,669,531 x | -12,136,598 x | -22,216,484 x |
| FCF Yield | -0% | -0% | -0% |
| Price to Book | 5.64 x | 3.4 x | 3.85 x |
| Nbr of stocks (in thousands) | 13,687 | 13,846 | 13,855 |
| Reference price 2 | 22,650 | 11,350 | 11,630 |
| Announcement Date | 3/1/22 | 3/1/23 | 2/29/24 |
1KRW in Million2KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales | - | - | - | 6,255 | 3,583 | 10,294 |
| EBITDA 1 | -1,681 | -5,559 | -7,542 | -6,487 | -11,480 | -9,865 |
| EBIT 1 | -1,789 | -5,734 | -7,853 | -6,870 | -11,982 | -10,508 |
| Operating Margin | - | - | - | -109.83% | -334.43% | -102.08% |
| Earnings before Tax (EBT) 1 | -2,827 | -13,989 | -28,610 | -6,678 | -11,406 | -11,586 |
| Net income 1 | -2,827 | -13,989 | -28,610 | -6,678 | -11,406 | -11,586 |
| Net margin | - | - | - | -106.76% | -318.34% | -112.54% |
| EPS 2 | -797.0 | -3,946 | -3,969 | -541.5 | -828.5 | -836.4 |
| Free Cash Flow | - | -3,353 | -4,314 | -18,575 | -11,017 | -6,244 |
| FCF margin | - | - | - | -296.97% | -307.48% | -60.66% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 12/31/19 | 2/29/20 | 4/1/21 | 3/1/22 | 3/1/23 | 2/29/24 |
1KRW in Million2KRW
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 2,503 | 16,809 | - | - | - | - |
| Net Cash position 1 | - | - | 9,763 | 37,530 | 23,446 | 22,408 |
| Leverage (Debt/EBITDA) | -1.489 x | -3.024 x | - | - | - | - |
| Free Cash Flow | - | -3,353 | -4,314 | -18,575 | -11,017 | -6,244 |
| ROE (net income / shareholders' equity) | - | 170% | 1,833% | -20% | -22.5% | -26.3% |
| ROA (Net income/ Total Assets) | - | -27.5% | -34.8% | -11% | -12.4% | -10.5% |
| Assets 1 | - | 50,918 | 82,224 | 60,827 | 92,284 | 110,644 |
| Book Value Per Share 2 | -474.0 | -4,165 | 933.0 | 4,019 | 3,335 | 3,021 |
| Cash Flow per Share 2 | 743.0 | 1,243 | 769.0 | 763.0 | 615.0 | 927.0 |
| Capex 1 | 21.5 | 591 | 397 | 17,449 | 3,411 | 120 |
| Capex / Sales | - | - | - | 278.97% | 95.21% | 1.16% |
| Announcement Date | 12/31/19 | 2/29/20 | 4/1/21 | 3/1/22 | 3/1/23 | 2/29/24 |
1KRW in Million2KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -49.36% | 60.33M | |
| +20.17% | 127B | |
| +24.67% | 117B | |
| +25.44% | 27.67B | |
| -17.74% | 20.33B | |
| -15.17% | 16.79B | |
| -15.21% | 15.63B | |
| +11.91% | 14.84B | |
| -47.10% | 14.65B | |
| +54.50% | 14.43B |
- Stock Market
- Equities
- A365270 Stock
- Financials curacle co.,ltd.
